News

Proluma™ PDLLA Launch and CE Certification

2024-02-14

본문

9e125bedc7f8168209340530a0c73ab0_1785468390_3332.png
9e125bedc7f8168209340530a0c73ab0_1785468574_2338.png

Next-generation collagen biostimulator: Proluma™ PDLLA 200 mg

Paris, France — 14 February 2024 — Genèse Labs has launched Proluma™ PDLLA, an injectable collagen stimulator built on polymer technology developed at the company’s French headquarters, together with completion of the Proluma™ trademark registration.